Lineage-dependent effects of aryl hydrocarbon receptor agonists contribute to liver tumorigenesis

Rodent cancer bioassays indicate that the aryl hydrocarbon receptor (AHR) agonist, 2,3,7,8-tetracholorodibenzo-p-dioxin (TCDD), causes increases in both hepatocytic and cholangiocytic tumors. Effects of AHR activation have been evaluated on rodent hepatic stem cells (rHpSCs) versus their descendants...

Descripción completa

Detalles Bibliográficos
Autores principales: Harrill, Joshua A, Parks, Bethany B, Wauthier, Eliane, Rowlands, J Craig, Reid, Lola M, Thomas, Russell S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2015
Materias:
Hepatobiliary Malignancies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303521/
https://www.ncbi.nlm.nih.gov/pubmed/25284723
http://dx.doi.org/10.1002/hep.27547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303521/
https://www.ncbi.nlm.nih.gov/pubmed/25284723
http://dx.doi.org/10.1002/hep.27547

Ejemplares similares